143 related articles for article (PubMed ID: 14739785)
1. Topotecan in small cell lung cancer: first or second line?
Campling B
Cancer Biol Ther; 2004 Jan; 3(1):94-5. PubMed ID: 14739785
[No Abstract] [Full Text] [Related]
2. Evolving role of topotecan in treating small-cell lung cancer.
Reddy K
Clin Lung Cancer; 2004 Mar; 5(5):270-2. PubMed ID: 15086965
[No Abstract] [Full Text] [Related]
3. The role of topotecan in treating small cell lung cancer: second-line treatment.
von Pawel J
Lung Cancer; 2003 Aug; 41 Suppl 4():S3-8. PubMed ID: 14565508
[TBL] [Abstract][Full Text] [Related]
4. Topotecan demonstrates significant activity in small-cell lung cancer.
Oncology (Williston Park); 1996 Mar; 10(3):422-3. PubMed ID: 8820456
[No Abstract] [Full Text] [Related]
5. Topotecan for the treatment of small-cell lung cancer.
Nicum SJ; O'Brien ME
Expert Rev Anticancer Ther; 2007 Jun; 7(6):795-801. PubMed ID: 17555389
[TBL] [Abstract][Full Text] [Related]
6. Topotecan demonstrates significant activity in recurrent small-cell lung cancer.
Oncology (Williston Park); 1996 Jan; 10(1):111. PubMed ID: 8924362
[No Abstract] [Full Text] [Related]
7. Foreword--new directions for topotecan in lung cancer treatment.
Stewart DJ
Oncologist; 2004; 9 Suppl 6():1-3. PubMed ID: 15616144
[No Abstract] [Full Text] [Related]
8. Topotecan in small cell lung cancer.
Schiller JH
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-27-S20-33. PubMed ID: 9425958
[TBL] [Abstract][Full Text] [Related]
9. Topotecan: a review of its efficacy in small cell lung cancer.
Ormrod D; Spencer CM
Drugs; 1999 Sep; 58(3):533-51. PubMed ID: 10493279
[TBL] [Abstract][Full Text] [Related]
10. Topotecan more effective than supportive care.
Nelson R
Lancet Oncol; 2007 Jan; 8(1):13. PubMed ID: 17348119
[No Abstract] [Full Text] [Related]
11. Topotecan in the first-line treatment of small cell lung cancer.
Stewart DJ
Oncologist; 2004; 9 Suppl 6():33-42. PubMed ID: 15616148
[TBL] [Abstract][Full Text] [Related]
12. Salvage treatment with topotecan in patients with irinotecan-refractory small cell lung cancer.
Park SH; Cho EK; Kim Y; Kyung SY; An CH; Lee SP; Park JW; Jeong SH; Lee JI; Choi SJ; Park J; Shin DB; Lee JH
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1009-14. PubMed ID: 18259751
[TBL] [Abstract][Full Text] [Related]
13. [Nogitecan hydrochloride].
Negoro S
Nihon Rinsho; 2002 May; 60 Suppl 5():370-3. PubMed ID: 12101691
[No Abstract] [Full Text] [Related]
14. [Effect of topotecan as a second line treatment in small cell lung cancer patients. Preliminary report].
Biernacka B; Krawczyk P; Buczkowski J; Siwiec A; Perzyło K; Milanowski J
Pneumonol Alergol Pol; 2010; 78(3):192-202. PubMed ID: 20461687
[TBL] [Abstract][Full Text] [Related]
15. Topotecan in the treatment of recurrent small cell lung cancer: an update.
Ardizzoni A
Oncologist; 2004; 9 Suppl 6():4-13. PubMed ID: 15616145
[TBL] [Abstract][Full Text] [Related]
16. Continuous infusion of low-dose topotecan: pharmacokinetics and pharmacodynamics during a phase II study in patients with small cell lung cancer.
Herben VM; ten Bokkel Huinink WW; Schot ME; Hudson I; Beijnen JH
Anticancer Drugs; 1998 Jun; 9(5):411-8. PubMed ID: 9660538
[TBL] [Abstract][Full Text] [Related]
17. Weekly topotecan in the management of lung cancer.
Treat J
Lung Cancer; 2003 Aug; 41 Suppl 4():S27-31. PubMed ID: 14565512
[TBL] [Abstract][Full Text] [Related]
18. A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer.
Shah C; Ready N; Perry M; Kirshner J; Gajra A; Neuman N; Garziano S
Lung Cancer; 2007 Jul; 57(1):84-8. PubMed ID: 17399850
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase II study of daily versus continuous-infusion schedules of topotecan in the treatment of extensive-stage small cell lung cancers.
Schaefer PL; Marks RS; Mahoney MR; Sloan JA; Bauman MD; Tazelaar HD; Kugler JW; Mailliard JA; Ebbert LP; Wiesenfeld M
Am J Clin Oncol; 2003 Jun; 26(3):236-40. PubMed ID: 12796591
[TBL] [Abstract][Full Text] [Related]
20. Topotecan in the treatment of relapsed small cell lung cancer patients with poor performance status.
Treat J; Huang CH; Lane SR; Levin J
Oncologist; 2004; 9(2):173-81. PubMed ID: 15047921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
